Article
Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy.
Viruses - 11 May 2022
Ridgway Harry, Chasapis Christos T, Kelaidonis Konstantinos, Ligielli Irene, Moore Graham J, Gadanec Laura Kate, Zulli Anthony, Apostolopoulos Vasso, Mavromoustakos Thomas, Matsoukas John M
Abstract excerpt
SARS-CoV-2 is a global challenge due to its ability to mutate into variants that spread more rapidly than the wild-type virus. Because the molecular biology of this virus has been studied in such great detail, it represents an archetypal paradigm for research into new antiviral drug therapies. The rapid evolution of SARS-CoV-2 in the human population is driven, in part, by mutations in the receptor-binding domain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
